使用目标介导药物处置模型对抗CD47抗体的最佳剂量
Seongmee Jeong1, Sung Young Lee2, Sung Ho Kim2
1College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
一种新型的抗体IMC- 002针对CD47增强癌细胞的细胞消化. 药物动力学模型为未来的临床研究提供了20 mg/ kg的最佳剂量方案.
科学领域:
- 免疫学
- 药理学
- 癌症学
背景情况:
- IMC- 002是一种针对CD47的全人类IgG4单克隆抗体.
- 它阻断了CD47-SIRPα相互作用,促进了巨细胞的细胞化.
研究的目的:
- 为IMC-002建立一个目标介导药物排放 (TMDD) 药物动力学 (PK) 模型.
- 使用基于模型的剂量来优化1b期研究的治疗方案.
主要方法:
- 在12名晚期固体瘤患者中进行的第1a期剂量升级研究中的药理学数据分析.
- 使用NONMEM软件 (v7.5) 与FOCEI进行PK分析.
- 开发了一种包含FcRn循环的半机械TMDD模型.
主要成果:
- TMDD模型成功解释了IMC-002的非线性PK特性.
- 没有发现有意义的共变量 (体重,性别,年龄).
- 模拟发现每3周20mg/ kg是最佳的剂量方案.
结论:
- 为IMC-002开发了一个强大的TMDD PK模型.
- 该模型为1b期研究中选择的剂量方案提供了强有力的理由.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
